{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:27:27Z","timestamp":1761823647465},"reference-count":28,"publisher":"Mark Allen Group","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Palliat Nurs"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:p> Most patients with cancers of the stomach, oesophagus or gastroesophageal junction ultimately develop metastatic or inoperable disease, rendering them incurable. They can, however, benefit from a variety of palliative interventions inving the multidisciplinary team, including chemotherapy, radiotherapy, endoluminal stenting, laser, or surgery. Often a combination of such strategies will be used to control symptoms, and maintain or improve quality of life. In this article, we review these multidisciplinary interventional approaches in patients with gastroesophageal cancers, and highlight future trends. <\/jats:p>","DOI":"10.12968\/ijpn.2006.12.7.21606","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T15:45:13Z","timestamp":1400859913000},"page":"306-317","source":"Crossref","is-referenced-by-count":3,"title":["Palliative treatments for patients with inoperable gastroesophageal cancers"],"prefix":"10.12968","volume":"12","author":[{"given":"Sanjay","family":"Popat","sequence":"first","affiliation":[{"name":"Kent Oncology Centre, Maidstone Hospital, Kent UK ME16 9QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanita","family":"Lopez","sequence":"additional","affiliation":[{"name":"Kent Oncology Centre, Maidstone Hospital, Kent UK ME16 9QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Chan","sequence":"additional","affiliation":[{"name":"Kent Oncology Centre, Maidstone Hospital, Kent UK ME16 9QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Waters","sequence":"additional","affiliation":[{"name":"Kent Oncology Centre, Maidstone Hospital, Kent UK ME16 9QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drag","family":"Rutter","sequence":"additional","affiliation":[{"name":"Kent Oncology Centre, Maidstone Hospital, Kent UK ME16 9QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"E Hill","sequence":"additional","affiliation":[{"name":"Kent Oncology Centre, Maidstone Hospital, Kent UK ME16 9QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5130","reference":[{"key":"p_78","first-page":"36","volume":"121","author":"Gastric","journal-title":"Oesophageal ECF FAMTX"},{"key":"p_80","first-page":"37","volume":"289","author":"Gastric","journal-title":"ECF MCF"},{"key":"p_82","first-page":"5","volume":"123","author":"Gastric","journal-title":"MMC"},{"key":"p_108","doi-asserted-by":"crossref","unstructured":"Adam A, Ellul J, Watkinson A etal 1997 Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement Radiology 202 344-348","DOI":"10.1148\/radiology.202.2.9015054"},{"key":"p_109","doi-asserted-by":"crossref","unstructured":"Ajani JA, Baker J, Pisters P etal 2002 CPT-11 plus cisplatin in patients with advanced untreated gastric or gastroesophageal junction carcinoma: results of a phase II study Cancer 94 641-646","DOI":"10.1002\/cncr.10279"},{"key":"p_110","doi-asserted-by":"crossref","unstructured":"Ajani JA, Fodor MB, Tjulandin SA etal 2005 Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated Advanced Gastric or Gastroesophageal Adenocarcinoma","DOI":"10.1200\/JCO.2005.17.376"},{"key":"p_111","doi-asserted-by":"crossref","unstructured":"Albertsson M, Ewers SB, Widmark H, Hambraeus G, Lillo-Gil R, Ranstam J, 1989 Evaluation of the palliative effect of radiotherapy for esophageal carcinoma Acta Oncol 28 267-270","DOI":"10.3109\/02841868909111261"},{"key":"p_112","doi-asserted-by":"crossref","unstructured":"Allum WH, Griffin SM, Watson A, Colin-Jones D 2002 Guidelines for the management of oesophageal and gastric cancer Gut 50 90005 1v-23","DOI":"10.1136\/gut.50.suppl_5.v1"},{"key":"p_113","unstructured":"American Cancer Society 2005 American Cancer Society Cancer Facts and Figures American Cancer Society Atlanta"},{"key":"p_114","doi-asserted-by":"crossref","unstructured":"Bleiberg H, Conroy T, Paillot B etal 1997 Randomized phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer EurJ Cancer 33 1216-1220","DOI":"10.1016\/S0959-8049(97)00088-9"},{"key":"p_115","doi-asserted-by":"crossref","unstructured":"Boku N, Ohtsu A, Shimada Y etal 1999 Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319-323","DOI":"10.1200\/JCO.1999.17.1.319"},{"key":"p_116","unstructured":"Cancer Reseach UK 2004 CancerStats Monograph 2004 Cancer Reseach UK London"},{"key":"p_117","doi-asserted-by":"crossref","unstructured":"Carter R, Smith JS, Anderson JR 1993 Palliation of malignant dysphagia using the Nd:YAG laser World J Surg 17 5 608-613","DOI":"10.1007\/BF01659121"},{"key":"p_119","doi-asserted-by":"crossref","unstructured":"Cunningham D, Humblet Y, Siena S etal 2004 Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer New Engl J Med 351 337-345","DOI":"10.1056\/NEJMoa033025"},{"key":"p_120","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609098483"},{"key":"p_121","doi-asserted-by":"crossref","unstructured":"Dallal HJ, Smith GD, Grieve DC, Ghosh S, Penman ID, Palmer KR 2001 A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma Gastrointest Endosc 54 549-557","DOI":"10.1067\/mge.2001.118947"},{"key":"p_122","volume-title":"Catanzano C 1996 Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study Gastrointest Endosc 43 478-482","author":"De Palma GD"},{"key":"p_123","doi-asserted-by":"crossref","unstructured":"Dormann A, Meisner S, Verin N, Wenk LA 2004 Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness Endoscopy 36 543-550","DOI":"10.1055\/s-2004-814434"},{"key":"p_124","unstructured":"Ekbom GA, Gleysteen JJ 1980 Gastric malignancy: resection for palliation Surgery 88 476-481"},{"key":"p_125","unstructured":"Eriksen J R 2002Palliation of non-resectable carcinoma of the cardia and oesophagus by argon beam coagulation Dan Med Bull 49 346-349"},{"key":"p_126","unstructured":"Ferlay J etal GLOBOCAN 2000: Cancer Incidence Mortality and Prevalence Worldwide Version 10 IARC CancerBase 5 2001 Lyon IARCPress"},{"key":"p_127","doi-asserted-by":"crossref","unstructured":"Glimelius B, Ekstrom K, Hoffman K etal 1997 Randomized comparison between chemotherapy plus best suortive care with best suortive care in advanced gastric cancer Ann Oncol 8 163-168","DOI":"10.1023\/A:1008243606668"},{"key":"p_128","volume-title":"Velde CJ 2002 Value of palliative resection in gastric cancer Br J Surg 89 1438-1443","author":"Hartgrink HH"},{"key":"p_129","doi-asserted-by":"crossref","unstructured":"Herskovic A, Martz K, al Sarraf M etal 1992 Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus New Engl J Med 326 1593-1598","DOI":"10.1056\/NEJM199206113262403"},{"key":"p_130","doi-asserted-by":"crossref","unstructured":"Homs MY, Eijkenboom WM, Coen VL etal 2003 High dose rate brachytherapy for the palliation of malignant dysphagia Radiothe Oncol 66 327-332","DOI":"10.1016\/S0167-8140(02)00410-3"},{"key":"p_131","doi-asserted-by":"crossref","unstructured":"Homs MY, Steyerberg EW, Eijkenboom WM etal 2004 Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomized trial Lancet 364 1497-1504","DOI":"10.1016\/S0140-6736(04)17272-3"},{"key":"p_132","doi-asserted-by":"crossref","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W etal 2004 Bevacizumab plus Irinotecan Fluorouracil and Leucovorin for Metastatic Colorectal Cancer The New Engl J Med 350 23 2335-2342","DOI":"10.1056\/NEJMoa032691"},{"key":"p_133","unstructured":"Ilson DH, Ajani J, Bhalla K etal 1998 Phase II trial of paclitaxel fluorouracil and cisplatin in patients"}],"container-title":["International Journal of Palliative Nursing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/pdf\/10.12968\/ijpn.2006.12.7.21606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T01:51:20Z","timestamp":1653357080000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/10.12968\/ijpn.2006.12.7.21606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.12968\/ijpn.2006.12.7.21606"],"URL":"https:\/\/doi.org\/10.12968\/ijpn.2006.12.7.21606","relation":{},"ISSN":["1357-6321","2052-286X"],"issn-type":[{"value":"1357-6321","type":"print"},{"value":"2052-286X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}